Levi & Korsinsky, LLP announces that a ORGO class action lawsuit has been filed on behalf of investors who purchased Organogenesis Holdings Inc. (ORGO) securities between March 17, 2021 and October 11, 2021. For more on the ORGO Lawsuit please contact us today.
According to the Organogenesis Holdings Inc. lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:
(i) Organogenesis improperly billed the federal government for its Affinity and PuraPly XT products by, among other things, setting the price for those products multiple times higher than similar products; (ii) the Company improperly induced doctors to use its Affinity and PuraPly XT products through lucrative reimbursements; (iii) as a result of all the foregoing, the Company’s revenue and profits derived from its Affinity and PuraPly XT products were at least in substantial part unsustainable; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in Organogenesis Holdings Inc. you have until February 8, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.